Company Filing History:
Years Active: 2002
Title: The Innovations of Eugene Robertson
Introduction
Eugene Robertson is a notable inventor based in Grayslake, IL (US). He has made significant contributions to the field of medical research, particularly in the detection of specific viruses. His work has implications for understanding and diagnosing conditions related to human T-cell lymphotropic virus type II (HTLV-II).
Latest Patents
Robertson holds a patent for "Methods for the detection of HTLV-II antibodies employing novel HTLV-II NRA envelope peptides." This invention relates to a novel human T-cell lymphotropic virus type II isolate designated NRA. HTLV-II was originally isolated from a patient with atypical hairy cell leukemia. Preliminary restriction analysis of this isolate demonstrated that it differs genetically from the prototypical HTLV-II isolate Mo. The claimed invention is particularly directed toward the gp46 and p21 envelope proteins encoded by the env gene. Methods and kits for the detection of HTLV-II antibodies employing these envelope proteins are also described. He has 1 patent to his name.
Career Highlights
Eugene Robertson is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to contribute to advancements in medical diagnostics and research.
Collaborations
Robertson has collaborated with notable colleagues, including Helen H Lee and Priscilla Swanson. These collaborations have likely enhanced the scope and impact of his research.
Conclusion
Eugene Robertson's innovative work in the detection of HTLV-II antibodies showcases his commitment to advancing medical science. His contributions are vital for improving diagnostic methods and understanding viral infections.